Document is current
Any future updates will be listed below
-
Authors
McKay, Andy
Pantoja, Carlos https://orcid.org/0000-0001-8322-7347
Hall, Richard
Matthews, Sarah
Spalding, Phil
Banerjee, Rajarshi
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02877602 at ClinicalTrials.govDocuments that mention this clinical trial
Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway
https://doi.org/10.1186/s41687-021-00363-5
-
Funding
Funding for this research was provided by:
Perspectum Diagnostics
- License Information
-
More Information
Article History
Received: 23 November 2020
Accepted: 31 August 2021
First Online: 10 September 2021
Declarations
:
: A total of 101 participants (62 Females, 39 Males males; aged 20–79, mean 51 years) provided informed consent to participate in this study in accordance with ethical approval from Oxford-C South Central Research Ethics Committee (Ref: 15/SC/0615).
: Not applicable.
: The PI (Principal Investigator) for this study, Dr. Rajarshi Banerjee, is a shareholder and CEO of Perspectum Diagnostics who have developed Liver<i>MultiScan™</i>. The study co-ordinator and lead investigator, Andrew McKay and co-author Carlos Pantoja work for Perspectum Diagnostics. Co-investigators and authors Richard Hall and Sarah Matthews are co-founders of the charity, Liver4Life (Registered Charity 1152618). Co-investigator and co-author Philip Spalding runs the charity Hep C Positive, which is part of Liver4Life.
